Kaplan B et al. |
Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. |
1999 |
Transplantation |
pmid:10075604
|
Takada S et al. |
Effect of hepatocyte growth factor on tacrolimus-induced nephrotoxicity in spontaneously hypertensive rats. |
1999 |
Transpl. Int. |
pmid:10080403
|
Kleindienst R et al. |
Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis carinii infection in a liver transplant patient receiving tacrolimus. |
1999 |
Clin Transplant |
pmid:10081638
|
Ghasemian SR et al. |
Tacrolimus vs Neoral in renal and renal/pancreas transplantation. |
1999 |
Clin Transplant |
pmid:10081648
|
Scott JS et al. |
Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083017
|
Meiser BM et al. |
The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083018
|
Bennett WM |
Renal complications after heart transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083019
|
Reichenspurner H et al. |
Tacrolimus-based immunosuppressive protocols in lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083062
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Undre NA et al. |
Low systemic exposure to tacrolimus correlates with acute rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083114
|
Melk A et al. |
P-glycoprotein expression in patients before and after kidney transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083115
|
|
Tacrolimus in renal transplantation: a comparison of induction vs noninduction therapy (triple therapy): three-month results. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083131
|
Lohmann R et al. |
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083151
|
Kato T et al. |
Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083158
|
Mueller AR et al. |
Is the use of marginal liver grafts justified? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083160
|
Molmenti E et al. |
Noncompliance after pediatric liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083164
|
Rayes N et al. |
Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir--how effective is it? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083200
|
Fischer L et al. |
Hepatitis G virus infection in liver transplant recipients. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083208
|
Murase N et al. |
Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083238
|
Schulz T et al. |
Mycophenolate mofetil/prednisolone/single-shot ATG with tacrolimus or cyclosporine in pancreas/kidney transplantation: first results of an ongoing prospective randomized trial. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083251
|